Skip to main content
Amgen10-Q: Market expansion

Multiple new products show explosive growth, including UPLIZNA (+$171M) and IMDELLTRA (+$177M).

What happened

Several recently launched or acquired products are experiencing rapid sales growth, such as UPLIZNA (up 188%) and IMDELLTRA (up 218%). This indicates successful market penetration and a strategic focus on scaling commercial operations, including sales, marketing, and distribution for these key growth drivers.

Source

SEC EDGARApr 30, 2026

Quarterly report (Form 10-Q)

Amgen 10-Q

Filing excerpt

Total UPLIZNA sales by geographic region were as follows (dollar amounts in millions): Three months ended March 31, 2026 $262 2025 $91

sec.gov/Archives/edgar/data/318154/000031815426000057/amgn-20260331.htmRead the full source

Other signals in this filing (11)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Market expansion

What this signalsFilings often name leadership changes, deals and spending plans.

Fiscal year end
03/31
Filed
Apr 30, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$171M (Year-over-year increase in UPLIZNA sales for Q1)
Percent
188% (Year-over-year change in UPLIZNA sales for Q1)

Details

CIK
318154
Accession number
0000318154-26-000057
Timeframe
Current quarter
Filing year
2026
Fiscal year
0
Why it matters
Scaling infrastructure needed

Topics and mentions

Regions named

  • U.S.
  • ROW

Extraction

Confidence
High
Relevance
80%
Sentiment
Positive
Detected
May 5, 2026
signal_type
sec-10q
signal_subtype
marketExpansion

Use this data

Get every 10-Q signal for Amgen and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Amgen this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/b8bdb3e1-079c-4c56-a940-4506e6838b0e returns this record as JSON. POST /v1/companies/enrich returns every signal for amgen.com.

{
  "signal_id": "b8bdb3e1-079c-4c56-a940-4506e6838b0e",
  "signal_type": "sec-10q",
  "signal_subtype": "marketExpansion",
  "detected_at": "2026-05-05T08:48:22.5+00:00",
  "company": {
    "name": "Amgen",
    "domain": "amgen.com"
  },
  "data": {
    "detail": "Several recently launched or acquired products are experiencing rapid sales growth, such as UPLIZNA (up 188%) and IMDELLTRA (up 218%). This indicates successful market penetration and a strategic focus on scaling commercial operations, including sales, marketing, and distribution for these key growth drivers.",
    "metrics": {
      "pct": 1.88,
      "timeframe": "current_quarter",
      "pct_context": "Year-over-year change in UPLIZNA sales for Q1",
      "dollar_context": "Year-over-year increase in UPLIZNA sales for Q1",
      "dollar_millions": 171
    },
    "summary": "Multiple new products show explosive growth, including UPLIZNA (+$171M) and IMDELLTRA (+$177M).",
    "excerpts": "Total UPLIZNA sales by geographic region were as follows (dollar amounts in millions): Three months ended March 31, 2026 $262 2025 $91",
    "relevance": 0.8,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/318154/000031815426000057/amgn-20260331.htm",
    "filing_date": "2026-04-30",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "03/31",
    "sales_relevance": "Scaling infrastructure needed",
    "signal_category": "market",
    "regions_mentioned": [
      "U.S.",
      "ROW"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.